These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 11489489)
1. VIP receptors as molecular targets of breast cancer: implications for targeted imaging and drug delivery. Dagar S; Sekosan M; Lee BS; Rubinstein I; Onyüksel H J Control Release; 2001 Jul; 74(1-3):129-34. PubMed ID: 11489489 [TBL] [Abstract][Full Text] [Related]
2. VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer: in vivo studies. Dagar S; Krishnadas A; Rubinstein I; Blend MJ; Onyüksel H J Control Release; 2003 Aug; 91(1-2):123-33. PubMed ID: 12932644 [TBL] [Abstract][Full Text] [Related]
3. Detection of VIP receptors in MNU-induced breast cancer in rats: implications for breast cancer targeting. Dagar S; Sekosan M; Rubinstein I; Onyüksel H Breast Cancer Res Treat; 2001 Jan; 65(1):49-54. PubMed ID: 11245339 [TBL] [Abstract][Full Text] [Related]
4. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Hadinoto K; Sundaresan A; Cheow WS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180 [TBL] [Abstract][Full Text] [Related]
5. Targeting breast cancer using pirarubicin-loaded vasoactive intestinal peptide grafted sterically stabilized micelles. Eskandari Z; Bahadori F; Yapaoz MA; Yenigun VB; Celikten M; Kocyigit A; Onyuksel H Eur J Pharm Sci; 2021 Jul; 162():105830. PubMed ID: 33819623 [TBL] [Abstract][Full Text] [Related]
6. Sterically stabilized phospholipids attenuate human neutrophils chemotaxis in vitro. Hatipoglu U; Gao X; Verral S; Séjourné F; Pitrak D; Alkan-Onyüksel H; Rubinstein I Life Sci; 1998; 63(8):693-9. PubMed ID: 9718098 [TBL] [Abstract][Full Text] [Related]
7. [Cellular toxicity and anti-tumor efficacy of iRGD modified doxorubixin loaded sterically stabilized liposomes]. Zhao B; Fan YC; Wang XQ; Dai WB; Zhang Q; Wang XL Yao Xue Xue Bao; 2013 Mar; 48(3):417-22. PubMed ID: 23724658 [TBL] [Abstract][Full Text] [Related]
8. Targeted drug delivery crossing cytoplasmic membranes of intended cells via ligand-grafted sterically stabilized liposomes. Lu J; Jeon E; Lee BS; Onyuksel H; Wang ZJ J Control Release; 2006 Feb; 110(3):505-13. PubMed ID: 16356575 [TBL] [Abstract][Full Text] [Related]
9. Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: in vitro and in vivo studies. Xie Y; Ye L; Zhang X; Cui W; Lou J; Nagai T; Hou X J Control Release; 2005 Jun; 105(1-2):106-19. PubMed ID: 15893839 [TBL] [Abstract][Full Text] [Related]
10. The study on brain targeting of the amphotericin B liposomes. Zhang X; Xie J; Li S; Wang X; Hou X J Drug Target; 2003 Feb; 11(2):117-22. PubMed ID: 12881198 [TBL] [Abstract][Full Text] [Related]
11. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery. He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805 [TBL] [Abstract][Full Text] [Related]
12. Intermembrane transfer of polyethylene glycol-modified phosphatidylethanolamine as a means to reveal surface-associated binding ligands on liposomes. Li WM; Xue L; Mayer LD; Bally MB Biochim Biophys Acta; 2001 Aug; 1513(2):193-206. PubMed ID: 11470091 [TBL] [Abstract][Full Text] [Related]
13. [Effect of RMP-7 and its derivatives on the transportation of liposome into the brain]. Zhang XB; Jin YG; Xie Y; Xu K; Hou XP Yao Xue Xue Bao; 2003 Nov; 38(11):867-70. PubMed ID: 14992004 [TBL] [Abstract][Full Text] [Related]
14. Effect of hepatocyte growth factor encapsulated in targeted liposomes on liver cirrhosis. Li F; Sun JY; Wang JY; Du SL; Lu WY; Liu M; Xie C; Shi JY J Control Release; 2008 Oct; 131(1):77-82. PubMed ID: 18692530 [TBL] [Abstract][Full Text] [Related]
15. Graphene oxide nanoribbons conjugated with 1, 2-distearoyl-sn-glycero-3 phosphoethanolamine-poly (ethylene glycol)-transferrin enhanced targeted delivery and cytotoxicity of raloxifene against breast cancer. Johnson AP; Jyothi SL; Shahid M; Venkatesh MP; Chidambaram SB; Osmani RA; Gangadharappa HV; Pramod K Int J Biol Macromol; 2024 Oct; 278(Pt 2):134772. PubMed ID: 39154682 [TBL] [Abstract][Full Text] [Related]
16. A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma. Dai W; Fan Y; Zhang H; Wang X; Zhang Q; Wang X Drug Deliv; 2015 Jan; 22(1):10-20. PubMed ID: 24735248 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of vasodilation elicited by VIP in sterically stabilized liposomes in vivo. Séjourné F; Suzuki H; Alkan-Onyüksel H; Gao XP; Ikezaki H; Rubinstein I Am J Physiol; 1997 Jul; 273(1 Pt 2):R287-92. PubMed ID: 9249562 [TBL] [Abstract][Full Text] [Related]
18. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319 [TBL] [Abstract][Full Text] [Related]
19. Targeted treatment of choroidal neovascularization using integrin-mediated sterically stabilized liposomes loaded with combretastatin A4. Ma L; Liu YL; Ma ZZ; Dou HL; Xu JH; Wang JC; Zhang X; Zhang Q J Ocul Pharmacol Ther; 2009 Jun; 25(3):195-200. PubMed ID: 19456253 [TBL] [Abstract][Full Text] [Related]
20. Liposomal VIP potentiates DNA synthesis in cultured oral keratinocytes. Rubinstein I; Dagar S; Sethi V; Krishnadas A; Onyüksel H Peptides; 2001 Apr; 22(4):671-5. PubMed ID: 11311738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]